BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jacobson KA, Gao Z, Matricon P, Eddy MT, Carlsson J. Adenosine A 2A receptor antagonists: from caffeine to selective non‐xanthines. Br J Pharmacol. [DOI: 10.1111/bph.15103] [Cited by in Crossref: 10] [Cited by in F6Publishing: 17] [Article Influence: 5.0] [Reference Citation Analysis]
Number Citing Articles
1 Bondar A, Alfonso-prieto M. Hydrogen-bond networks for proton couplings in G-Protein coupled receptors. Front Phys 2022;10:963716. [DOI: 10.3389/fphy.2022.963716] [Reference Citation Analysis]
2 Stephens GJ, Shukla AK. Targeting the cell's gatekeepers for novel drug discovery. Br J Pharmacol 2022. [PMID: 35393664 DOI: 10.1111/bph.15831] [Reference Citation Analysis]
3 Rajagopal R, Baltazar MT, Carmichael PL, Dent MP, Head J, Li H, Muller I, Reynolds J, Sadh K, Simpson W, Spriggs S, White A, Kukic P. Beyond AOPs: A Mechanistic Evaluation of NAMs in DART Testing. Front Toxicol 2022;4:838466. [DOI: 10.3389/ftox.2022.838466] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
4 Xu Y, Ning Y, Zhao Y, Peng Y, Luo F, Zhou Y, Li P. Caffeine Functions by Inhibiting Dorsal and Ventral Hippocampal Adenosine 2A Receptors to Modulate Memory and Anxiety, Respectively. Front Pharmacol 2022;13:807330. [PMID: 35185566 DOI: 10.3389/fphar.2022.807330] [Reference Citation Analysis]
5 Francesconi O, Ienco A, Papi F, Dolce M, Catastini A, Nativi C, Roelens S. A Sulfonated Tweezer-Shaped Receptor Selectively Recognizes Caffeine in Water. J Org Chem 2022. [PMID: 35107278 DOI: 10.1021/acs.joc.1c02620] [Reference Citation Analysis]
6 Conti F, Lazzara F, Romano GL, Platania CBM, Drago F, Bucolo C. Caffeine Protects Against Retinal Inflammation. Front Pharmacol 2021;12:824885. [PMID: 35069225 DOI: 10.3389/fphar.2021.824885] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
7 Ballante F, Kooistra AJ, Kampen S, de Graaf C, Carlsson J. Structure-Based Virtual Screening for Ligands of G Protein-Coupled Receptors: What Can Molecular Docking Do for You? Pharmacol Rev 2021;73:527-65. [PMID: 34907092 DOI: 10.1124/pharmrev.120.000246] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
8 Yan W, Ling L, Wu Y, Yang K, Liu R, Zhang J, Zhao S, Zhong G, Zhao S, Jiang H, Xie C, Cheng J. Structure-Based Design of Dual-Acting Compounds Targeting Adenosine A2A Receptor and Histone Deacetylase as Novel Tumor Immunotherapeutic Agents. J Med Chem 2021;64:16573-97. [PMID: 34783558 DOI: 10.1021/acs.jmedchem.1c01155] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Gessi S, Poloni TE, Negro G, Varani K, Pasquini S, Vincenzi F, Borea PA, Merighi S. A2A Adenosine Receptor as a Potential Biomarker and a Possible Therapeutic Target in Alzheimer's Disease. Cells 2021;10:2344. [PMID: 34571993 DOI: 10.3390/cells10092344] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
10 Faudone G, Arifi S, Merk D. The Medicinal Chemistry of Caffeine. J Med Chem 2021;64:7156-78. [PMID: 34019396 DOI: 10.1021/acs.jmedchem.1c00261] [Cited by in Crossref: 1] [Cited by in F6Publishing: 17] [Article Influence: 1.0] [Reference Citation Analysis]
11 Merighi S, Poloni TE, Terrazzan A, Moretti E, Gessi S, Ferrari D. Alzheimer and Purinergic Signaling: Just a Matter of Inflammation? Cells 2021;10:1267. [PMID: 34065393 DOI: 10.3390/cells10051267] [Cited by in Crossref: 1] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
12 Merighi S, Battistello E, Casetta I, Gragnaniello D, Poloni TE, Medici V, Cirrincione A, Varani K, Vincenzi F, Borea PA, Gessi S. Upregulation of Cortical A2A Adenosine Receptors Is Reflected in Platelets of Patients with Alzheimer's Disease. J Alzheimers Dis 2021;80:1105-17. [PMID: 33646165 DOI: 10.3233/JAD-201437] [Cited by in Crossref: 5] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
13 Stahl EL, Bohn LM. Decaf or regular? Energizing the caffeine receptor. Cell 2021;184:1659-60. [PMID: 33798438 DOI: 10.1016/j.cell.2021.03.016] [Reference Citation Analysis]
14 Merighi S, Poloni TE, Pelloni L, Pasquini S, Varani K, Vincenzi F, Borea PA, Gessi S. An Open Question: Is the A2A Adenosine Receptor a Novel Target for Alzheimer's Disease Treatment? Front Pharmacol 2021;12:652455. [PMID: 33828485 DOI: 10.3389/fphar.2021.652455] [Cited by in Crossref: 3] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
15 Jacobson KA, IJzerman AP, Müller CE. Medicinal chemistry of P2 and adenosine receptors: Common scaffolds adapted for multiple targets. Biochem Pharmacol 2021;187:114311. [PMID: 33130128 DOI: 10.1016/j.bcp.2020.114311] [Cited by in Crossref: 7] [Cited by in F6Publishing: 11] [Article Influence: 3.5] [Reference Citation Analysis]
16 Elnagdy M, Barve S, McClain C, Gobejishvili L. cAMP Signaling in Pathobiology of Alcohol Associated Liver Disease. Biomolecules 2020;10:E1433. [PMID: 33050657 DOI: 10.3390/biom10101433] [Cited by in Crossref: 2] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
17 Zhang J, Yan W, Duan W, Wüthrich K, Cheng J. Tumor Immunotherapy Using A2A Adenosine Receptor Antagonists. Pharmaceuticals (Basel) 2020;13:E237. [PMID: 32911819 DOI: 10.3390/ph13090237] [Cited by in Crossref: 3] [Cited by in F6Publishing: 9] [Article Influence: 1.5] [Reference Citation Analysis]